Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Oncol.

Sec. Breast Cancer

A Comparative Dosimetric Study of Hypofractionated Radiotherapy with Different Target Volume Delineation Approaches in Breast Cancer Patients After Implant-Based Reconstruction

Provisionally accepted
Lipeng  DingLipeng Ding1,2Xu  WangXu Wang1Zhangcai  ZhengZhangcai Zheng1Jianping  LongJianping Long1Guoying  MiuGuoying Miu1Tao  YangTao Yang1Shuxia  LiShuxia Li1Na  DongNa Dong1Liying  GaoLiying Gao1*
  • 1Gansu Provincial Maternal and Child Health Hospital, Lanzhou, China
  • 2The First School of Clinical Medicine, Lanzhou University, Lanzhou, China, Lanzhou, China

The final, formatted version of the article will be published soon.

【Purpose】This study dosimetrically compares hypofractionated VMAT plans using the updated ESTRO-ACROP guidelines versus conventional delineation in patients undergoing immediate implant-based breast reconstruction after mastectomy. 【Methods】We retrospectively enrolled 22 patients with immediate implant-based reconstruction post-mastectomy (12 left-sided, 10 right-sided), treated between January 2022 and June 2025. All patients underwent CT simulation; those with left-sided cancer were positioned using deep inspiration breath-hold (DIBH), and those with right-sided cancer under free breathing. For each patient, conventional (C-TVD) and ESTRO-ACROP guideline-based (E-TVD) target volumes were independently delineated on the same CT dataset. Hypofractionated VMAT plans were designed using a 6-MV beam, single-isocenter, dual-arc technique, prescribing 40.05 Gy in 15 fractions to the planning target volume (PTV). All plans were normalized to ensure ≥95% PTV coverage by the prescribed dose. Dose-volume parameters for targets and organs at risk (OARs) were then compared between the two delineation approaches. 【Results】The conformity index (CI) of E-TVD was inferior to that of C-TVD; however, E-TVD achieved superior 95% prescription dose coverage of the target volume. Compared with C-TVD, E-TVD resulted in significantly lower V₂₀ and Dₘₑₐₙ to the ipsilateral lung, with differences reaching statistical significance (P < 0.05). For the heart, E-TVD was associated with significantly lower V₂₀, as well as lower Dₘₐₓ and Dₘₑₐₙ to the left anterior descending coronary artery (LAD), with all differences reaching statistical significance (P < 0.05). Subgroup analyses stratified by left versus right breast cancer revealed that in left breast cancer patients, E-TVD resulted in statistically significant reductions in ipsilateral lung V₂₀, V₁₀, and Dₘₑₐₙ; bilateral lung V₂₀; heart V₂₀; LAD Dₘₐₓ and Dₘₑₐₙ; and contralateral breast Dₘₑₐₙ (all P < 0.05). In right breast cancer patients, E-TVD was associated with significantly lower ipsilateral lung Dₘₑₐₙ and contralateral breast Dₘₑₐₙ (both P < 0.05). 【Conclusions 】In patients with breast cancer who undergo total mastectomy followed by immediate implant-based breast reconstruction, the E-TVD approach confers superior protection to organs at risk.

Keywords: breast cancer, ESTRO-ACROP, Immediate breast reconstruction, implants, Radiotherapy, VMAT

Received: 25 Jan 2025; Accepted: 11 Dec 2025.

Copyright: © 2025 Ding, Wang, Zheng, Long, Miu, Yang, Li, Dong and Gao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Liying Gao

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.